老年肺结核患者经济毒性及其影响因素的研究进展

doi:10.19982/j.issn.1000-6621.20250512

摘要/Abstract

摘要：

肺结核(pulmonary tuberculosis, PTB)是全球重大公共卫生挑战之一,老年患者常因治疗周期长、合并症多、收入单一等特点,成为经济毒性的高发人群。经济毒性不仅严重影响患者及家庭的生活质量,还容易导致治疗中断,甚至放弃治疗,进而加剧肺结核的广泛传播。因此,降低老年肺结核患者的经济毒性,是实现终结结核病流行战略的必要条件。本研究旨在综述老年肺结核患者经济毒性现状、影响因素及现有的一些干预措施,为临床医护人员标准化评估提供参考,为优化针对老年人群的医疗保障政策提供理论依据,助力缩小老年群体与世界卫生组织提出的“终结结核病流行”目标的差距。

关键词: 结核,肺, 老年, 经济毒性, 综述

Abstract:

Pulmonary tuberculosis (PTB) remains one of the major global public health challenges. Elderly patients with PTB often become a high-risk population for financial toxicity due to prolonged treatment duration, multiple comorbidities, and a single source of income. Financial toxicity not only severely impairs the quality of life of patients and their families but also frequently leads to treatment interruption or even abandonment, thereby exacerbating the widespread transmission of PTB. Therefore, reducing financial toxicity among elderly PTB patients is an essential prerequisite for achieving the World Health Organization’s End TB Strategy. This review aims to summarize the current status, influencing factors, and existing interventions regarding financial toxicity in this population. It provides a reference for standardized clinical assessment and offers a theoretical basis for optimizing medical insurance policies targeting the elderly population, helping to narrow the gap between this group and the WHO End TB Strategy targets.

Key words: Tuberculosis, Pulmonary, Elderly, Financial Toxicity, Review

中图分类号:

苑楠, 刘宇, 杜桂春. 老年肺结核患者经济毒性及其影响因素的研究进展[J]. 中国防痨杂志, 2026, 48(6): 903-908. doi: 10.19982/j.issn.1000-6621.20250512

Yuan Nan, Liu Yu, Du Guichun. Research progress on financial toxicity and its influencing factors in elderly patients with pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2026, 48(6): 903-908. doi: 10.19982/j.issn.1000-6621.20250512

参考文献 65

[1]	World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization, 2024.
[2]	World Health Organization. The end TB strategy. Geneva: World Health Organization, 2015.
[3]	李媛媛, 谢晶晶, 李树涛, 等. 2024年WHO全球结核病报告:全球与中国关键数据分析. 新发传染病电子杂志, 2024, 9(6): 92-98. doi:10.19871/j.cnki.xfcrbzz.2024.06.016.
[4]	张灿有, 陈卉, 张慧, 等. 2011—2020年全国65岁及以上老年人肺结核报告发病情况分析. 中华疾病控制杂志, 2022, 26(11): 1252-1258. doi:10.16462/j.cnki.zhjbkz.2022.11.003.
[5]	宋媛媛, 李涛, 夏辉, 等. 1997—2023年全国肺结核报告发病流行病学特征. 中国防痨杂志, 2024, 46(10): 1198-1208. doi:10.19982/j.issn.1000-6621.20240382.
[6]	Dong Z, Wang QQ, Yu SC, et al. Age-period-cohort analysis of pulmonary tuberculosis reported incidence, China, 2006—2020. Infect Dis Poverty, 2022, 11(1): 85. doi:10.1186/s40249-022-01009-4.
[7]	Di Gennaro F, Vittozzi P, Gualano G, et al. Active pulmonary tuberculosis in elderly patients: a 2016—2019 retrospective analysis from an italian referral hospital. Antibiotics (Basel), 2020, 9(8): 489. doi:10.3390/antibiotics9080489.
[8]	Zafar SY, Abernethy AP. Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park), 2013, 27(2): 80-81, 149.
[9]	Valero-Elizondo J, Chouairi F, Khera R, et al. Atherosclerotic cardiovascular disease, cancer, and financial toxicity among adults in the United States. JACC CardioOncol, 2021, 3(2): 236-246. doi:10.1016/j.jaccao.2021.02.006.
[10]	Dau NQ, Kim D, Peled H. Reducing the risk of financial toxicity in the real-world setting for heart failure care. JACC Heart Fail, 2022, 10(11): 885. doi:10.1016/j.jchf.2022.06.015.
[11]	Patel MR. Financial toxicity in diabetes: The state of what we know. Curr Diab Rep, 2025, 25(1): 32. doi:10.1007/s11892-025-01588-0.
[12]	Prawitz AD, Garman ET, Sorhaindo B, et al. InCharge financial distress/financial well-being scale: development, administration, and score interpretation. J Financ Couns Plan, 2006, 17(1): 34-50. doi:10.1037/t60365-000.
[13]	朱小玲, 王浪, 田艳珍, 等. 慢性病经济毒性量表的汉化及信效度检验. 医学新知, 2025, 35(8): 940-946. doi:10.12173/j.issn.1004-5511.202410161.
[14]	de Souza JA, Yap BJ, Hlubocky FJ, et al. The development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer, 2014, 120(20): 3245-3253. doi:10.1002/cncr.28814.
[15]	于慧会, 毕雪, 刘运泳. 中文版癌症患者报告结局的经济毒性量表信度和效度研究. 中华流行病学杂志, 2017, 38(8): 1118-1120. doi:10.3760/cma.j.issn.0254-6450.2017.08.024.
[16]	陈薇薇, 邹圣强, 袁嘉, 等. 中青年肺结核患者恐惧疾病进展的潜在剖面及影响因素分析. 中国防痨杂志, 2026, 48(1): 84-93. doi:10.19982/j.issn.1000-6621.20250284.
[17]	Dar MA, Chauhan R, Murti K, et al. Development and validation of subjective financial distress questionnaire (SFDQ): a patient reported outcome measure for assessment of financial toxicity among radiation oncology patients. Front Oncol, 2022, 11: 819313. doi:10.3389/fonc.2021.819313.
[18]	Khera N. Reporting and grading financial toxicity. J Clin Oncol, 2014, 32(29): 3337-3338. doi:10.1200/JCO.2014.57.8740.
[19]	陈凤. 结直肠癌患者经济毒性的潜在类别及影响因素研究. 成都: 电子科技大学, 2025. doi:10.27005/d.cnki.gdzku.2024.006083.
[20]	Badr H, Han J, Mims M. Development and validation of FinTox: A new screening tool to assess cancer-related financial toxicity. Cancer Med, 2024, 13(15): e7306. doi:10.1002/cam4.7306.
[21]	Chen H, Bi H, Li P, et al. Evaluation of pulmonary tuberculosis disease burden in Shenyang, China, 2023. BMC Infect Dis, 2025, 25(1): 166. doi:10.1186/s12879-025-10572-8.
[22]	Fan S, Abulizi A, You Y, et al. Predicting hospitalization costs for pulmonary tuberculosis patients based on machine learning. BMC Infect Dis, 2024, 24(1): 875. doi:10.1186/s12879-024-09771-6.
[23]	Ghazy RM, El Saeh HM, Abdulaziz S, et al. A systematic review and meta-analysis of the catastrophic costs incurred by tuberculosis patients. Sci Rep, 2022, 12(1): 558. doi:10.1038/s41598-021-04345-x.
[24]	Ma X, Huang A, Chen H, et al. Household economic burden and catastrophic expenditures in non-resistant tuberculosis patients: cross-sectional survey in Guizhou, China. Front Public Health, 2025, 13: 1510195. doi:10.3389/fpubh.2025.1510195.
[25]	World Health Organization. Tuberculosis patient cost surveys: a handbook. Geneva: World Health Organization, 2017.
[26]	张丽萍, 柳湘洁, 刘晓霞, 等. 武汉地区老年结核病耐药病例流行特征及疾病负担研究. 实用临床医药杂志, 2025, 29(6): 30-33. doi:10.7619/jcmp.20244924.
[27]	李雪秋, 邝浩斌, 王挺, 等. 广州市耐多药肺结核患者自付医疗费用及影响因素分析. 中国防痨杂志, 2024, 46(4): 411-417. doi:10.19982/j.issn.1000-6621.20230448.
[28]	D’Silva OA, Lancione S, Ananthakrishnan O, et al. The catastrophic cost of TB care: Understanding costs incurred by individuals undergoing TB care in low-, middle-, and high-income settings-A systematic review. PLoS Glob Public Health, 2025, 5(4): e0004283. doi:10.1371/journal.pgph.0004283.
[29]	Long Q, Smith H, Zhang T, et al. Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC Public Health, 2011, 11: 393. doi:10.1186/1471-2458-11-393.
[30]	张馨月, 王瑜, 熊丽蓉. 1990—2021年中国耐多药结核病负担趋势及其危险因素分析. 现代预防医学, 2025, 52(9): 1544-1549. doi:10.20043/j.cnki.MPM.202412525.
[31]	梁博文, 鲜馥阳, 李波, 等. 238例老年耐多药肺结核临床特点及不良治疗结局影响因素分析. 中国热带医学, 2024, 24(3): 276-281. doi:10.13604/j.cnki.46-1064/r.2024.03.08.
[32]	Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin, 2018, 68(2): 153-165. doi:10.3322/caac.21443.
[33]	杨晓明, 陈海兰, 朱翠敏, 等. 老年肺结核患者负性情绪调查及影响因素分析. 国际精神病学杂志, 2025, 52(2): 606-609. doi:10.13479/j.cnki.jip.2025.02.023.
[34]	Samal J, Dehury RK, Thomas MB, et al. Prevalence and predictors of depression in tuberculosis patients in india: a systematic review and meta-analysis. Discov Ment Health, 2025, 5(1): 104. doi:10.1007/s44192-025-00248-9.
[35]	杨文璐. 首发耐药结核病患者家庭抗逆力变化轨迹及其影响因素的纵向研究. 成都: 成都中医药大学, 2024. doi:10.26988/d.cnki.gcdzu.2024.000513.
[36]	丁加琪, 闻俊, 孙馨, 等. 肺结核患者经济毒性的研究进展. 护理管理杂志, 2025, 25(8): 668-671, 685. doi:10.3969/j.issn.1671-315x.2025.08.005.
[37]	张译友, 田媛, 帕孜来提·赛登等. 脑卒中患者经济毒性现状及影响因素分析. 中国临床护理, 2023, 15(3): 183-186. doi:10.3969/j.issn.1674-3768.2023.03.013.
[38]	陶继华. 膀胱癌患者经济毒性风险预测模型的构建及验证. 成都: 电子科技大学, 2025. doi:10.27202/d.cnki.gkmyc.2024.000944.
[39]	Filetti M, Lombardi P, Gentile G, et al. The financial toll of cancer: uncovering the links between financial toxicity and symptom burden. Oncologist, 2025, 30(6): oyaf131. doi:10.1093/oncolo/oyaf131.
[40]	徐玲, 曾司甯, 郭子宁, 等. 脑卒中患者经济毒性潜在剖面分析及其影响因素研究. 军事护理, 2024, 41(4): 51-55. doi:10.3969/j.issn.2097-1826.2024.04.013.
[41]	邹潘琳, 林丽桑, 谢宝缘, 等. 乳腺癌化疗患者经济毒性现状及影响因素. 吉林医学, 2024, 45(11): 2759-2763. doi:10.3969/j.issn.1004-0412.2024.11.048.
[42]	沈雅琳, 汤利萍, 曹英, 等. 输尿管皮肤造口患者经济毒性状况及影响因素分析. 护理学杂志, 2022, 37(10): 26-29. doi:10.3870/j.issn.1001-4152.2022.10.026.
[43]	季静芬, 黎萌, 伍雅琴, 等. 结直肠癌患者决策自我效能及智谋对其经济毒性的影响. 护理管理杂志, 2024, 24(6): 518-522. doi:10.3969/j.issn.1671-315x.2024.06.012.
[44]	He X, Chen J, Zhang L, et al. Identifying the factors affecting financial toxicity status in patients with middle and advanced colorectal cancer: a cross-sectional study. Front Public Health, 2024, 12: 1421314. doi:10.3389/fpubh.2024.1421314.
[45]	况艺, 裘佳佳, 汤立晨, 等. 乳腺癌术后患者经济毒性水平及影响因素的纵向研究. 护士进修杂志, 2024, 39(19): 2023-2030. doi:10.16821/j.cnki.hsjx.2024.19.002.
[46]	Li Y, Chen L, Hao X, et al. Financial toxicity and its association with psychological distress and quality of life: Comparison between young, middle and old cancer patients. Psychooncology, 2025, 34(10): e70312. doi:10.1002/pon.70312.
[47]	Liu S, Xie Y, Li T, et al. Social support, quality of life, and financial toxicity among patients with hepatocellular carcinoma. J Hepatocell Carcinoma, 2025, 12: 1711-1723. doi:10.2147/JHC.S523284.
[48]	Kim S, Perry LM, Mossman B, et al. Financial burden and physical and emotional quality of life in COPD, heart failure, and kidney failure. PLoS One, 2024, 19(7): e0306620. doi:10.1371/journal.pone.0306620.
[49]	张慧, 赵雁林, 严俊. 我国结核病预防控制进展与挑战. 中国预防医学杂志, 2025, 26(1): 1-7. doi:10.16506/j.1009-6639.2025.01.001.
[50]	何裕畅, 叶志辉, 张秀莲, 等. 老年肺结核患者治疗的研究进展. 中国防痨杂志, 2025, 47(S1): 361-363.
[51]	Meghji J, Gregorius S, Madan J, et al. The long term effect of pulmonary tuberculosis on income and employment in a low income, urban setting. Thorax, 2021, 76(4): 387-395. doi:10.1136/thoraxjnl-2020-215338.
[52]	何昱颖, 阮云洲, 陈玮, 等. 贵州省耐多药结核病定点医院耐多药肺结核患者直接医疗费用影响因素的广义线性模型分析. 微量元素与健康研究, 2023, 40(5): 73-76.
[53]	Lee S, Kim MJ, Lee SH, et al. Comparison of disability-adjusted life years (DALYs) and economic burden on people with drug-susceptible tuberculosis and multidrug-resistant tuberculosis in Korea. Front Public Health, 2022, 10: 848370. doi:10.3389/fpubh.2022.848370.
[54]	韦柳迎, 荆玮, 刘志峰, 等. 含贝达喹啉方案治疗南宁市耐多药/利福平耐药肺结核患者成本效果分析:一项回顾性队列研究. 中国防痨杂志, 2025, 47(7): 914-920. doi:10.19982/j.issn.1000-6621.20240553.
[55]	Shen T, Liu Y, Shang J, et al. Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology, 2019, 156(8): 2230-2241.e11. doi:10.1053/j.gastro.2019.02.002.
[56]	中华医学会结核病学分会. 老年肺结核诊断与治疗专家共识(2023版). 中华结核和呼吸杂志, 2023, 46(11): 1068-1084. doi:10.3760/cma.j.cn112147-20230921-00182.
[57]	Zhou M, Peng Y, Liu K, et al. Direct medical expenses and influencing factors of MDR/RR-TB in eastern China: Based on data from multi-hospital information systems. Risk Manag Healthc Policy, 2023, 16: 1955-1965. doi:10.2147/RMHP.S420082.
[58]	Lu L, Jiang Q, Hong J, et al. Catastrophic costs of tuberculosis care in a population with internal migrants in China. BMC Health Serv Res, 2020, 20(1): 832. doi:10.1186/s12913-020-05686-5.
[59]	Stracker N, Hanrahan C, Mmolawa L, et al. Risk factors for catastrophic costs associated with tuberculosis in rural South Africa. Int J Tuberc Lung Dis, 2019, 23(6): 756-763. doi:10.5588/ijtld.18.0519.
[60]	张金萍, 周小平, 丁志伟, 等. 基于双重差分法的疾病诊断相关分组支付方式改革对肺结核患者住院费用影响的研究. 中国防痨杂志, 2025, 47(11): 1515-1521. doi:10.19982/j.issn.1000-6621.20250198.
[61]	李改云, 吴杨昊天, 丁明峰, 等. 取消药品加成政策前后肺结核患者住院费用的中断时间序列分析. 中国防痨杂志, 2022, 44(10): 1071-1078. doi:10.19982/j.issn.1000-6621.20220220.
[62]	Zhang M, Wang X, Shao M, et al. Financial toxicity of informal caregivers of colorectal cancer patients: A cross-sectional study. Eur J Oncol Nurs, 2024, 69: 102519. doi:10.1016/j.ejon.2024.102519.
[63]	Fuady A, Anindhita M, Hanifah M, et al. Codeveloping a community-based, peer-led psychosocial support intervention to reduce stigma and depression among people with tuberculosis and their households in Indonesia: a mixed-methods participatory action study. NPJ Prim Care Respir Med, 2025, 35(1): 7. doi:10.1038/s41533-024-00407-5.
[64]	Gu C, Liu B, Wang H, et al. The chain-mediating roles of social support and depression in the relationship between tuberculosis knowledge and self-management: a cross-sectional study based on the ABC-X model. Front Public Health, 2025, 13: 1640626. doi:10.3389/fpubh.2025.1640626.
[65]	Ponnuchamy L, Majhi G, Shreedevi AU, et al. Post-intervention psychosocial outcomes among tuberculosis patients in India: The role of community engagement. Cureus, 2025, 17(11): e96064. doi:10.7759/cureus.96064.